Skip to main content
Premium Trial:

Request an Annual Quote

Med BioGene Taps JRG for Strategic Advice to Help Launch Cancer Dx

NEW YORK (GenomeWeb News) — Med BioGene said today that it has hired JRG Ventures for strategic business advice as it moves to commercialize a new genomic-based diagnostic test for lymphoma.
 
JRG will help the company define its partnering and commercialization strategy as it prepares to roll out its clinical laboratory LymphExpress Dx test.
 
JRG advises companies involved in life sciences, healthcare, and information technology, partnering, licensing, corporate and regulatory strategies, and operations and logistics.
 
Financial terms of the agreement were not released.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.